|
| Issue Date | Title | Author(s) | Type |
| 2019 | Pembrolizumab Plus Chemotherapy for Advanced NSCLC Without Tumor PD-L1 Expression: Pooled Analysis of KN021G, KN189 and KN407 | Borghaei, H.; Langer, C.; Paz-Ares, L.; Rodriguez Abreu, Delvys; Halmos, B.; Papadimitrakopoulou, V.; Garassino, M.; Houghton, B.; Kurata, T.; Cheng, Y.; Lin, J.; Pietanza, M. C.; Piperdi, B.; Gadgeel, S. | Actas de congresos | |
| 2019 | KRAS mutational status and efficacy in KEYNOTE-189: Pembrolizumab (pembro) plus chemotherapy (chemo) vs placebo plus chemo as first-line therapy for metastatic non-squamous NSCLC | Gadgeel, S.; Rodriguez-Abreu, D.; Felip, E.; Esteban, E.; Speranza, G.; Reck, M.; Hui, R.; Boyer, M.; Garon, E. B.; Horinouchi, H.; Cristescu, R.; Aurora-Garg, D.; Lunceford, J.; Kobie, J.; Ayers, M.; Piperdi, B.; Pietanza, M. C.; Garassino, M. C. | Actas de congresos | |
| 2019 | Evaluation of TMB in KEYNOTE-189: Pembrolizumab Plus Chemotherapy vs Placebo Plus Chemotherapy for Nonsquamous NSCLC | Garassino, M.; Rodriguez-Abreu, D.; Gadgeel, S.; Esteban, E.; Felip, E.; Speranza, G.; Reck, M.; Hui, R.; Boyer, M.; Cristescu, R.; Aurora-Garg, D.; Albright, A.; Loboda, A.; Kobie, J.; Lunceford, J.; Ayers, M.; Lubiniecki, G.; Piperdi, B.; Pietanza, M. C.; Garon, E. | Actas de congresos | |